Clinical application of 1,5-anhydroglucitol and the research progress
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    1,5-Anhydroglucitol (1,5-AG) is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. The stable level of 1,5-AG is rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. Thus, 1,5-AG can be used as a validated marker of short-term glycemic control. This article reviewed the features and research progress of 1,5-AG and assessed its advantages as well as limitations as a glycemic marker in clinical practice.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: November 28,2014
  • Published:
Article QR Code